Industry-Leading AI Platform Empowers Life Sciences Companies with Custom Solutions, Redefining Data Access and Analysis
Ferma is continuously evolving our AI solutions to help our clients stay ahead of the curve. This PM360 distinction is a recognition of the people and expertise behind our innovative technology.”— Andrew Yukawa
ZoomRx, a pioneering force in technological solutions for the life sciences sector, is proud to announce its recent recognition in PM360’s 12th Annual Innovations Issue. ZoomRx has been awarded for its groundbreaking innovations in the life sciences and healthcare industries, particularly through its state-of-the-art generative AI technology, Ferma.
Over the course of the year, the Ferma platform has served as an incubator and innovation hub for life sciences companies to develop their own custom AI solutions. By acting as a vessel for custom generative AI applications, Ferma has significantly advanced the way life sciences professionals access, analyze, and leverage unstructured and structured data.
"Ferma is continuously evolving our AI solutions to help ensure our life sciences clients stay ahead of the curve. This PM360 distinction serves as a recognition of the people and expertise behind our innovative technology, and I couldn’t be more excited for our team. Using this distinction as momentum, we look forward to continuing our pursuit of developing breakthrough offerings for more efficient and effective operations," said Andrew Yukawa, Product Manager.
In its 12th year, PM360’s Innovations Issue is published each December. This issue was established as the industry’s first-ever guide to the year’s most innovative advancements and has since become a premier resource. This year, the issue expanded to include 13 categories: Artificial Intelligence; Clinical Trials; Consumer Tech and Wellness; Core Business Processes; Data and Cybersecurity; Employee Acquisition, Development, and Programs; Health Technology Non-Consumer; Life Sciences; Marketing Technology or Services; Metaverse; Payers/Insurance Companies; Startups; and Telehealth/Telemedicine.
In total, 56 innovations were selected by PM360’s editorial staff for inclusion in the issue out of hundreds of submissions.
“We know the importance of innovation, which is why we expanded this issue to include the most fascinating and groundbreaking achievements being made in all areas of life sciences, healthcare, and marketing,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovations we selected are changing how our industry operates to create better ways to develop treatments, run companies, educate physicians, improve diagnosis, and much more to ultimately find better ways to serve patients.”
About ZoomRx
ZoomRx is a leading life sciences solutions provider relied on by over 15 of the top 20 global biopharma firms. Our technology and expertise enable our clients to better serve healthcare providers, patients, and other key stakeholders.
Through visionary creativity, proprietary technology, and an expert consulting team, ZoomRx provides valuable solutions that enable clients to optimize the effectiveness of their operations, drive growth, and create life-changing and lifesaving therapies.
For more information, visit www.zoomrx.com or www.ferma.ai and follow us on LinkedIn.
Andrew Yukawa
ZoomRx
andrew.yukawa@zoomrx.com
Visit us on social media:
LinkedIn
